These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9611252)

  • 21. Heterozygous PU.1 mutations are associated with acute myeloid leukemia.
    Mueller BU; Pabst T; Osato M; Asou N; Johansen LM; Minden MD; Behre G; Hiddemann W; Ito Y; Tenen DG
    Blood; 2002 Aug; 100(3):998-1007. PubMed ID: 12130514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and gene expression of transcription factors, PU.1 and C/EBPα driving transcription from the tumor necrosis factor α promoter in Japanese flounder, Paralichthys olivaceus.
    Hikima J; Ohtani M; Kondo H; Hirono I; Jung TS; Aoki T
    Dev Comp Immunol; 2011 Mar; 35(3):304-13. PubMed ID: 20951726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EVI1 Impairs myelopoiesis by deregulation of PU.1 function.
    Laricchia-Robbio L; Premanand K; Rinaldi CR; Nucifora G
    Cancer Res; 2009 Feb; 69(4):1633-42. PubMed ID: 19208846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types.
    Ness SA; Kowenz-Leutz E; Casini T; Graf T; Leutz A
    Genes Dev; 1993 May; 7(5):749-59. PubMed ID: 7684005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription.
    Nerlov C; Querfurth E; Kulessa H; Graf T
    Blood; 2000 Apr; 95(8):2543-51. PubMed ID: 10753833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates.
    Walsh JC; DeKoter RP; Lee HJ; Smith ED; Lancki DW; Gurish MF; Friend DS; Stevens RL; Anastasi J; Singh H
    Immunity; 2002 Nov; 17(5):665-76. PubMed ID: 12433372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of the mononuclear phagocyte system during mouse embryogenesis: the role of transcription factor PU.1.
    Lichanska AM; Browne CM; Henkel GW; Murphy KM; Ostrowski MC; McKercher SR; Maki RA; Hume DA
    Blood; 1999 Jul; 94(1):127-38. PubMed ID: 10381505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PU.1/Spi-B regulation of c-rel is essential for mature B cell survival.
    Hu CJ; Rao S; Ramirez-Bergeron DL; Garrett-Sinha LA; Gerondakis S; Clark MR; Simon MC
    Immunity; 2001 Oct; 15(4):545-55. PubMed ID: 11672537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS.
    Berclaz PY; Carey B; Fillipi MD; Wernke-Dollries K; Geraci N; Cush S; Richardson T; Kitzmiller J; O'connor M; Hermoyian C; Korfhagen T; Whitsett JA; Trapnell BC
    Am J Respir Cell Mol Biol; 2007 Jan; 36(1):114-21. PubMed ID: 16917076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein expression and constitutive phosphorylation of hematopoietic transcription factors PU.1 and C/EBP beta in acute myeloid leukemia blasts.
    Iida H; Towatari M; Iida M; Tanimoto M; Kodera Y; Ford AM; Saito H
    Int J Hematol; 2000 Feb; 71(2):153-8. PubMed ID: 10745625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
    Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
    J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells.
    Smith LT; Hohaus S; Gonzalez DA; Dziennis SE; Tenen DG
    Blood; 1996 Aug; 88(4):1234-47. PubMed ID: 8695841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C/EBPalpha directs monocytic commitment of primary myeloid progenitors.
    Wang D; D'Costa J; Civin CI; Friedman AD
    Blood; 2006 Aug; 108(4):1223-9. PubMed ID: 16645168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of CCAAT/enhancer-binding protein alpha or PU.1 in hematopoietic stem cells leads to their reduced self-renewal and proliferation.
    Fukuchi Y; Ito M; Shibata F; Kitamura T; Nakajima H
    Stem Cells; 2008 Dec; 26(12):3172-81. PubMed ID: 18787208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C/EBPepsilon is a myeloid-specific activator of cytokine, chemokine, and macrophage-colony-stimulating factor receptor genes.
    Williams SC; Du Y; Schwartz RC; Weiler SR; Ortiz M; Keller JR; Johnson PF
    J Biol Chem; 1998 May; 273(22):13493-501. PubMed ID: 9593684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor.
    Dahl R; Walsh JC; Lancki D; Laslo P; Iyer SR; Singh H; Simon MC
    Nat Immunol; 2003 Oct; 4(10):1029-36. PubMed ID: 12958595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
    Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of PML is essential for activation of C/EBP epsilon and PU.1 to accelerate granulocytic differentiation.
    Tagata Y; Yoshida H; Nguyen LA; Kato H; Ichikawa H; Tashiro F; Kitabayashi I
    Leukemia; 2008 Feb; 22(2):273-80. PubMed ID: 17989716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity.
    Kamath MB; Houston IB; Janovski AJ; Zhu X; Gowrisankar S; Jegga AG; DeKoter RP
    Leukemia; 2008 Jun; 22(6):1214-25. PubMed ID: 18354487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1.
    Ziliotto R; Gruca MR; Podder S; Noel G; Ogle CK; Hess DA; DeKoter RP
    Exp Hematol; 2014 Mar; 42(3):204-217.e1. PubMed ID: 24316397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.